HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
4317studies shown
Showing 1,633-1,644 of 4,317
Drug study icon
RecruitingNCT06830044

Milsaperidone added to medication for major depression

About this title

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Read the official source — NCT06830044
What is this study about?

This study evaluates the safety and effectiveness of Milsaperidone for people with depression.

Multiple locations, including Phoenix
DepressionMedication studyAges 18–65
Countries
United States, Bulgaria, Czechia, + 1 other
Sponsor
Vanda Pharmaceuticals
Other study type icon
RecruitingNCT05865652

Brain energy and membrane markers in people at high risk of psychosis

About this title

Evaluation of Membrane Phospholipid and Energy Metabolism in Subjects at High Risk of Psychotic Transition

Read the official source — NCT05865652
Official study title

Evaluation of Membrane Phospholipid Metabolism and Cellular Energy Metabolism in Subjects at High Risk of Psychotic Transition

In Poitiers
SchizophreniaStudy assessmentsAges 15–25
Countries
France
Sponsor
Centre Hospitalier Henri Laborit
Other study type icon
RecruitingNCT06864156

Blood markers, mood, anxiety, and fatigue in long COVID

About this title

Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

Read the official source — NCT06864156
Official study title

Evaluation of MicroRNAs and Vitamin B12 Expression in Subjects with Neurologic Symptoms of Depression, Anxiety and Fatigue in Long COVID-19

In Mexico City
Depression, AnxietyObservational studyAges 18–65
Countries
Mexico
Sponsor
Instituto Nacional de Rehabilitacion
Drug study icon
RecruitingNCT07288333

NBI-1117570 for behavioral symptoms in adults hospitalized with schizophrenia

About this title

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

Read the official source — NCT07288333
What is this study about?

This study evaluates the safety and effectiveness of NBI-1117570 for people with schizophrenia.

Multiple locations, including Kazanlak
SchizophreniaMedication studyAges 18–55
Countries
United Kingdom, Bulgaria, Romania
Sponsor
Neurocrine Biosciences (Biotech company)
Behavioral study icon
RecruitingNCT04900064

Guided self-help CBT added to primary care mental health support

About this title

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial

Read the official source — NCT04900064
Official study title

Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial for Superiority and Non-superiority Comparisons of Effects on Patients' Everyday Function, Symptoms, and Experiences

Multiple locations, including Malmö
Adjustment disorder, Anxiety, ...Behavioural studyAges 18+
Countries
Sweden
Sponsor
Linnaeus University
Behavioral study icon
RecruitingNCT06792071

Radically open DBT for adolescents with eating disorders

About this title

Evaluation of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders

Read the official source — NCT06792071
Official study title

Feasibility and Efficacy of Radically Open Dialectical Behavior Therapy for Youth At Risk for Developing Severe and Enduring Eating Disorders

In Uppsala
Eating disordersBehavioural studyAges 14–19
Countries
Sweden
Sponsor
Uppsala University Hospital

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.